glp-1 vs glp-3 differences Semaglutide vs. Other Receptor Agonists Comparisons of glucagon-like peptide-1 (GLP-1),

Clinical studies have shown that patients can expect significant weight loss (around 5-10% of their body weight) after about 6 months of consistent use, although individual results may vary based on lifestyle factors such as diet and exercise

In new findings recently released, researchers from Johns Hopkins University School of Medicine and the New York Medical College in Valhalla report that Type 2 diabetic adults taking this class of medications, known as GLP-1s, face an increased risk of developing cognitive impairment after a decade of use

It suggests that our gut bacteria affect body weight and metabolic health

How Expiration and Stability Affect Treatment Outcomes Expired or improperly stored semaglutide may appear unchanged but contain degraded active ingredient, reducing therapeutic efficacy